Advances in the treatment of human T-cell lymphotropic virus type-I associated myelopathy

B Mashkani, M Jalili Nik, SA Rezaee… - Expert Review of …, 2023 - Taylor & Francis
ABSTRACT Introduction Nearly 2–3% of those 10 to 20 million individuals infected with the
Human T-cell lymphotropic virus type-1 (HTLV-1); are predisposed to developing HTLV-1 …
被引用次数：1 相关文章

Advances in the treatment of human T-cell lymphotropic virus type-I associated myelopathy

B Mashkani, MJ Nik, SA Rezaee… - Expert review of … - pubmed.ncbi.nlm.nih.gov
Introduction Nearly 2-3% of those 10 to 20 million individuals infected with the Human T-cell
lymphotropic virus type-1 (HTLV-1); are predisposed to developing HTLV-1-associated …

Advances in the treatment of human T-cell lymphotropic virus type-I associated myelopathy.

B Mashkani, SA Rezaee, R Boostani - Expert Review of …, 2023 - europepmc.org
Nearly 2-3% of those 10 to 20 million individuals infected with the Human T-cell
lymphotropic virus type-1 (HTLV-1); are predisposed to developing HTLV-1-associated …